Variants in the APOB gene was associated with Ischemic Stroke susceptibility in Chinese Han male population

被引:16
作者
Zhou, Feng [1 ]
Guo, Tie [1 ]
Zhou, Lv [1 ]
Zhou, Yanhui [1 ]
Yu, Dan [1 ]
机构
[1] Cent S Univ, Dept Neurol, Affiliated Haikou Hosp, Xiangya Med Coll, Haikou 570208, Hainan, Peoples R China
关键词
Ischemic Stroke; APOB; gene polymorphism; massARRAY; DENSITY-LIPOPROTEIN CHOLESTEROL; HEART-DISEASE; RISK; ATHEROSCLEROSIS; ENVIRONMENT; LIPIDS; MEN;
D O I
10.18632/oncotarget.23369
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Stroke is an extremely complicated disease caused by multiple factors. Epidemiological studies have shown that genetic factors contribute to the pathogenesis of stroke. There is still little research on the effect of ApoB gene on stroke in Chinese Han population. The purpose of our research was to explore the effect of ApoB gene polymorphism on the genetic susceptibility to Ischemic Stroke in Chinese Han male population. Materials and methods: 7 polymorphisms in ApoB gene were selected and genotyped using Sequenom MassARRAY in 325 ischemic stroke male patients and 399 healthy male controls in Chinese Han population. The association between ApoB gene and genetic susceptibility to Ischemic Stroke was performed by the chi(2) test, genetic model analysis and haplotype analysis. Results: In the allele model, ApoB rs1042034 "T" allele and rs673548 "G" allele increased the risk of the Ischemic Stroke (rs1042034: OR=1.29, 95% CI: 1.02-1.63, p=0.030; rs673548: OR=1.28, 95% CI: 1.02-1.62, p=0.034). Logistic regression analysis found that ApoB rs1042034 and rs673548 increased the risk of Ischemic Stroke in the log-additive model, the odds of having Ischemic Stroke would be 1.28-fold and 1.27-fold with the variant allele, respectively. We also found that the risk of individuals carrying the ApoB rs693 "AA-AG" genotype had Ischemic Stroke risk of 1.52-fold of carrying "GG" genotype in the dominant model. The haplotype analysis shown that "TAG" haplotype raised the risk of Ischemic Stroke (OR=1.52, 95% CI: 1.02-2.27, p=0.0042). Conclusion: The polymorphisms of the ApoB gene may affect Ischemic Stroke occurrence.
引用
收藏
页码:2249 / 2254
页数:6
相关论文
共 20 条
  • [11] Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans
    Kathiresan, Sekar
    Melander, Olle
    Guiducci, Candace
    Surti, Aarti
    Burtt, Noel P.
    Rieder, Mark J.
    Cooper, Gregory M.
    Roos, Charlotta
    Voight, Benjamin F.
    Havulinna, Aki S.
    Wahlstrand, Bjorn
    Hedner, Thomas
    Corella, Dolores
    Tai, E. Shyong
    Ordovas, Jose M.
    Berglund, Goran
    Vartiainen, Erkki
    Jousilahti, Pekka
    Hedblad, Bo
    Taskinen, Marja-Riitta
    Newton-Cheh, Christopher
    Salomaa, Veikko
    Peltonen, Leena
    Groop, Leif
    Altshuler, David M.
    Orho-Melander, Marju
    [J]. NATURE GENETICS, 2008, 40 (02) : 189 - 197
  • [12] Novel gene-by-environment interactions: APOB and NPC1L1 variants affect the relationship between dietary and total plasma cholesterol
    Kim, Daniel S.
    Burt, Amber A.
    Ranchalis, Jane E.
    Jarvik, Ella R.
    Rosenthal, Elisabeth A.
    Hatsukami, Thomas S.
    Furlong, Clement E.
    Jarvik, Gail P.
    [J]. JOURNAL OF LIPID RESEARCH, 2013, 54 (05) : 1512 - 1520
  • [13] The role of lipid-related genes, aging-related processes, and environment in healthspan
    Kulminski, Alexander M.
    Culminskaya, Irina
    Arbeev, Konstantin G.
    Ukraintseva, Svetlana V.
    Stallard, Eric
    Arbeeva, Liubov
    Yashin, Anatoli I.
    [J]. AGING CELL, 2013, 12 (02): : 237 - 246
  • [14] Genome-Wide Association Study Pinpoints a New Functional Apolipoprotein B Variant Influencing Oxidized Low-Density Lipoprotein Levels But Not Cardiovascular Events AtheroRemo Consortium
    Makela, Kari-Matti
    Seppala, Ilkka
    Hernesniemi, Jussi A.
    Lyytikainen, Leo-Pekka
    Oksala, Niku
    Kleber, Marcus E.
    Scharnagl, Hubert
    Grammer, Tanja B.
    Baumert, Jens
    Thorand, Barbara
    Jula, Antti
    Hutri-Kahonen, Nina
    Juonala, Markus
    Laitinen, Tomi
    Laaksonen, Reijo
    Karhunen, Pekka J.
    Nikus, Kjell C.
    Nieminen, Tuomo
    Laurikka, Jari
    Kuukasjarvi, Pekka
    Tarkka, Matti
    Viik, Jari
    Klopp, Norman
    Illig, Thomas
    Kettunen, Johannes
    Ahotupa, Markku
    Viikari, Jorma S. A.
    Kahonen, Mika
    Raitakari, Olli T.
    Karakas, Mahir
    Koenig, Wolfgang
    Boehm, Bernhard O.
    Winkelmann, Bernhard R.
    Marz, Winfried
    Lehtimaki, Terho
    [J]. CIRCULATION-CARDIOVASCULAR GENETICS, 2013, 6 (01) : 73 - 81
  • [15] Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response
    Rodrigues, A. C.
    Sobrino, B.
    Genvigir, F. D. V.
    Willrich, M. A. V.
    Arazi, S. S.
    Dorea, E. L.
    Bernik, M. M. S.
    Bertolami, M.
    Faludi, A. A.
    Brion, M. J.
    Carracedo, A.
    Hirata, M. H.
    Hirata, R. D. C.
    [J]. CLINICA CHIMICA ACTA, 2013, 417 : 8 - 11
  • [16] Effects of Aggrenox and aspirin on plasma endothelial nitric oxide synthase and oxidised low-density lipoproteins in patients after ischaemic stroke The AGgrenox versus Aspirin Therapy Evaluation (AGATE) Biomarker Substudy
    Serebruany, Victor
    Sani, Yanti
    Eisert, Christian
    Schevchuck, Alex
    Fong, Alan
    Hanley, Dan
    [J]. THROMBOSIS AND HAEMOSTASIS, 2011, 105 (01) : 81 - 87
  • [17] Cholesterol and other lipids predict coronary heart disease and ischaemic stroke in the elderly, but only in those below 70 years
    Simons, LA
    Simons, J
    Friedlander, Y
    McCallum, J
    [J]. ATHEROSCLEROSIS, 2001, 159 (01) : 201 - 208
  • [18] High-density lipoprotein cholesterol and risk of stroke in Japanese men and women - The Oyabe study
    Soyama, Y
    Miura, K
    Morikawa, Y
    Nishijo, M
    Nakanishi, Y
    Naruse, Y
    Kagamimori, S
    Nakagawa, H
    [J]. STROKE, 2003, 34 (04) : 863 - 868
  • [19] High-density lipoprotein cholesterol and risk of ischemic stroke mortality - A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study
    Tanne, D
    Yaari, S
    Goldbourt, U
    [J]. STROKE, 1997, 28 (01) : 83 - 87
  • [20] High-throughput oncogene mutation profiling in human cancer
    Thomas, Roman K.
    Baker, Alissa C.
    DeBiasi, Ralph M.
    Winckler, Wendy
    LaFramboise, Thomas
    Lin, William M.
    Wang, Meng
    Feng, Whei
    Zander, Thomas
    MacConnaill, Laura E.
    Lee, Jeffrey C.
    Nicoletti, Rick
    Hatton, Charlie
    Goyette, Mary
    Girard, Luc
    Majmudar, Kuntal
    Ziaugra, Liuda
    Wong, Kwok-Kin
    Gabriel, Stacey
    Beroukhim, Rameen
    Peyton, Michael
    Barretina, Jordi
    Dutt, Amit
    Emery, Caroline
    Greulich, Heidi
    Shah, Kinjal
    Sasaki, Hidefumi
    Gazdar, Adi
    Minna, John
    Armstrong, Scott A.
    Mellinghoff, Ingo K.
    Hodi, F. Stephen
    Dranoff, Glenn
    Mischel, Paul S.
    Cloughesy, Tim F.
    Nelson, Stan F.
    Liau, Linda M.
    Mertz, Kirsten
    Rubin, Mark A.
    Moch, Holger
    Loda, Massimo
    Catalona, William
    Fletcher, Jonathan
    Signoretti, Sabina
    Kaye, Frederic
    Anderson, Kenneth C.
    Demetri, George D.
    Dummer, Reinhard
    Wagner, Stephan
    Herlyn, Meenhard
    [J]. NATURE GENETICS, 2007, 39 (03) : 347 - 351